1-12 of 12
H Ludwig
Close
Sort by
Journal Articles

The Effect of Hemoglobin (Hb) Level at ESA Initiation on Outcomes in Cancer Patients (pts) with Chemotherapy-Induced Anemia (CIA): A Patient-Based Meta-Analysis from 6 Randomized, Placebo-Controlled Trials (RCTs) of Darbepoetin alfa (DA).

J. Crawford, MD, D. Henry, MD, J. Vansteenkiste, MD, H. Ludwig, MD, T. Lillie, MD, A. Fleishman, MS, J. Glaspy, MD
Journal: Blood
Blood (2007) 110 (11): 3780.
https://doi.org/10.1182/blood.V110.11.3780.3780
Published: 2007
Journal Articles

Evaluating the Safety of Erythropoiesis-Stimulating Agents (ESAs) in Patients with Breast Cancer, Lung Cancer, and Hematologic Malignancies: A Meta-Analysis of Randomized, Controlled Trials.

J. Glaspy, MD, D. Henry, MD, J. Vansteenkiste, MD, H. Ludwig, MD, T. Lillie, MD, D. Tomita, MPH, J. Crawford, MD
Journal: Blood
Blood (2007) 110 (11): 3669.
https://doi.org/10.1182/blood.V110.11.3669.3669
Published: 2007
Journal Articles

Human polymorphism of P-selectin glycoprotein ligand 1 attributable to variable numbers of tandem decameric repeats in the mucinlike region

Brief Report
Vahid Afshar-Kharghan, Reyhan Diz-Küçükkaya, Erwin H. Ludwig, Ali J. Marian, José A. López
Journal: Blood
Blood (2001) 97 (10): 3306–3307.
https://doi.org/10.1182/blood.V97.10.3306
Published: 2001
Journal Articles

Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance

J Drach, J Angerler, J Schuster, C Rothermundt, R Thalhammer, OA Haas, U Jager, M Fiegl, K Geissler, H Ludwig
Journal: Blood
Blood (1995) 86 (10): 3915–3921.
https://doi.org/10.1182/blood.V86.10.3915.bloodjournal86103915
Published: 1995
Journal Articles

Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments]

H Ludwig, E Fritz, C Leitgeb, M Pecherstorfer, H Samonigg, J Schuster
Journal: Blood
Blood (1994) 84 (4): 1056–1063.
https://doi.org/10.1182/blood.V84.4.1056.1056
Published: 1994
Journal Articles

Hyperreactive cellular immunity in multiple myeloma [letter; comment]

G Reibnegger, H Wachter, M Krainer, H Ludwig, M Herold, H Huber
Journal: Blood
Blood (1992) 79 (8): 2174–2176.
https://doi.org/10.1182/blood.V79.8.2174.2174
Published: 1992
Journal Articles

Interleukin-6 is a prognostic factor in multiple myeloma [letter] [see comments]

H Ludwig, DM Nachbaur, E Fritz, M Krainer, H Huber
Journal: Blood
Blood (1991) 77 (12): 2794–2795.
https://doi.org/10.1182/blood.V77.12.2794.2794
Published: 1991
Journal Articles

Shortened platelet half-life in multiple myeloma

E Fritz, H Ludwig, W Scheithauer, H Sinzinger
Journal: Blood
Blood (1986) 68 (2): 514–520.
https://doi.org/10.1182/blood.V68.2.514.514
Published: 1986
Journal Articles

5q- chromosome in acute leukemia with lymphoid morphology and expression of myeloid membrane determinants

OA Haas, P Bettelheim, W Schmidmeier, H Gadner, H Ludwig, O Majdic, U Schulz
Journal: Blood
Blood (1985) 65 (6): 1342–1348.
https://doi.org/10.1182/blood.V65.6.1342.bloodjournal6561342
Published: 1985
Journal Articles

Prognostic relevance of cellular morphology in multiple myeloma

E Fritz, H Ludwig, M Kundi
Journal: Blood
Blood (1984) 63 (5): 1072–1079.
https://doi.org/10.1182/blood.V63.5.1072.1072
Published: 1984
Journal Articles

Genetic aspects of susceptibility to multiple myeloma

H Ludwig, W Mayr
Journal: Blood
Blood (1982) 59 (6): 1286–1291.
https://doi.org/10.1182/blood.V59.6.1286.1286
Published: 1982
Journal Articles

Phagocytic plasma cells in a patient with multiple myeloma

H Ludwig, M Pavelka
Journal: Blood
Blood (1980) 56 (2): 173–176.
https://doi.org/10.1182/blood.V56.2.173.173
Published: 1980